Visit to Pharmaceutical Firms by Kurtyka, Carol
Volume 37 | Issue 2 Article 6
1975
Visit to Pharmaceutical Firms
Carol Kurtyka
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/iowastate_veterinarian
Part of the Medicinal and Pharmaceutical Chemistry Commons, and the Veterinary Medicine
Commons
This Article is brought to you for free and open access by the Journals at Iowa State University Digital Repository. It has been accepted for inclusion in
Iowa State University Veterinarian by an authorized editor of Iowa State University Digital Repository. For more information, please contact
digirep@iastate.edu.
Recommended Citation
Kurtyka, Carol (1975) "Visit to Pharmaceutical Firms," Iowa State University Veterinarian: Vol. 37 : Iss. 2 , Article 6.
Available at: https://lib.dr.iastate.edu/iowastate_veterinarian/vol37/iss2/6
Visit To Pharmacutical Firms
by
Carol Kurtyka*
The annual junior class trip to drug
houses began Sunday morning, March 2,
1975, at 7:00 a.m., when 56 students, two
instructors, and two wives boarded two
charter buses, taking them to places where
few of them had ever been before.
The first two days were spent at Eli
Lilly and Company in Indianapolis, one
day at Abbott Labs in North Chicago, and
the final day at the Upjohn Company in
Kalamazoo, Michigan.
During this time through the use of
tours, lectures, films, and panel discus-
sions, each of the drug companies took
their turn to explain to the class what they
considered to be the most important as-
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pects of their pharmaceutical divisions.
These aspects varied in de~ai1. from com-
pany to company, but basically fell into
four dimensions, these being research,
manufacturing, marketing, and quality
control.
Research is a very important part, if
not the most important part of the phar-
maceutical industry. The drug companies
realize this, for on the average, 5-10% of
all expenditures of the business are de-
voted to research. Also, it was noted that
the quality of the facilities for research
were far more sophisticated than were the
facilities for manufacturing or marketing.
Getting a new drug on the market is by
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no means an easy task. For each new
drug, it takes all average of 4-10 years
of research and anywhere from $1-7
million.
For each new drug product, many char-
acteristics must be determined. The drug's
form (capsule, tablet, injectable, ointment,
cream), toxicity, safety, clinical effective-
lless, has (if pertinent), stability pattern,
and residue it may leave, must be de-
termined. Its compatibility with packag-
ing materials and its ability to be manu-
factured economically are also very im-
portant. To determine all of these factors,
many tests must be conducted. Three
series of experiments-acute, subacute,
and chronic-are run to determine tox-
icity alone.
To develop a human drug, tests in three
animal species are required. Two of these
must be non-rodents, the most common
ones being the dog, and monkey.
Many animal drugs are spin-offs of
human drugs and need only to be tested
in the target species the company is seek-
ing ~pproval for, plus one rodent and one
non-rodent species.
Not all research is directed toward spe-
cific products. Some of it is very basic
work in such areas as anti-viral drugs,
cancer drugs, metabolic diseases, antibi-
otic and vitamin structure determlllation,
just to mention a few. However, all com-
panies appear to restrict research studies
to areas of their particular interests in the
pharnlaceutical market.
Most of the money in research is being
devoted to developing new antibiotics,
anthelminthics, and products along these
lines. Little, if any, work is being done
on veterinary biologicals, such as vac-
cines.
Manufacturing is the second dimension
of the pharmaceutical industry. To those
who have never witnessed mass assembly
line production before, the tours through
these areas were real eye-openers. Even
though most of the drug companies al-
lowed the workers to change jobs every
half hour to every two hours, it was diffi-
cult to imagine how monotonous their
jobs must have become, day after day. It
was hard to swallow the fact that many
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of these workers have become rather
dehumanized and are essentially ap-
pe;ndages to the various machines. Those
of us with a profession should be very
thankful for the fact that we have a fu-
ture ahead of us that consists of some-
thing more than putting four little boxes
into a bigger box or checking to see that
all the bottles in a row are properly stop-
pered.
The third dimension is marketing of
the products. It was surprising to learn
that all the drug companies had at least
one line of products that is sold directly
to the farnler. In some companies, almost
their en~ire line is sold directly to the
farmer. Ethical sales are strictly company
policy Ollce the federal regulations are
met. One thing found that was hard to
believe, was that out of one batch of prod-
uct, some bottles are labelled for use by
a licensed veterinarian only, while other
bottles of the identical product are labelled
for use by the general public.
Another interesting observation in-
volved the business transactions between
the various companies. One company
would make the drug and sell it to the
other company who would put their own
label on it stating "made forn instead of
"made by."
Because of all the time and expense
necessary to get approval of a drug for use
in various species for different conditions,
most drugs are only labelled for a few
specific uses and only in one or two spe-
cies. Employing these drugs in other in-
stances is left entirely to the veterinarian.
He is responsible for whatever adverse re-
actions may occur, as the drug companies
will not stand behind him in an instance
where the drug is not approved for that
use.
There is a trend developing now toward
specialization in drug production. This
will tend to elinlinate competition and
may at the same time raise prices.
The fourth dimension of pharmaceuti-
cal industry is quality control, a term that
was repeated over and over by the various
companies. The user of the product must
be assured of its purity and potency. All
the products are inspected throughout the
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manufacturing process, as the finished
product, and some after a specific time in
incubation. If there is any deviation from
the standard for that product, that specific
batch of product is usually destroyed, as
too much time and expense would be
wasted tryi11g to recycle it.
Once a drug has received approval, its
testing does not stop there. The older
drugs must meet the approval of the new
regulations or they will be removed from
the market. There is a continuing chal-
lenge in finding ways to obtain greater
yields and to improve products.
Tours such as these taken by the junior
class are very important to these compa-
nies. This is exemplified by the fact that
one of the companies has an entertaining
budget of $1~ million/year spent giving
tours to 11 veterinary colleges, 30 medi-
cal colleges, 65 pharmacy colleges, plus
other individual groups. This company
spent on the average of $100/person for
this tour.
The companies consider these tours im-
portant enough to have the top leaders
in each of the various departments talk
to us directly or be available for questions
during panel discussions or during at-
tenda11ce at the evening ba11quets.
The drug companies also meant for
these tours to be fun and full of enjoy-
ment. Free movie passes were provided,
"places of interest" were recommended,
and even a Playboy Club key was provided
for those who so desired.
The meals were fabulous, almost to a
point beyond the limits of most appetites.
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Each evening there was a happy hour fol-
lowed by a six-course banquet.
Many new sights were seen by the stu-
de11ts, from two canlels in suburban In-
dianapolis to looking over Chicago at
night from the 103rd fioor of the Sears
Tower, only two nights after seeing the
movie "The Towering Inferno." Now that
took real courage I
Numerous activities were indulged in,
from "bolting" to e11ding up in the wrong
bed, to dancing up a storm at "The Top-
pers."
The bus rides seemed to find most of
the passengers either talking, playing
cards, reading, or sleeping. The trip home
seemed to filld most of them doing the
last-sleeping. The bus ride was by no
means uneventful. It was full of excite-
ment, from engine trouble, to getting lost,
to arguing with a Vega over the road.
One had to be prompt on this trip; if you
were only three minutes late, you found
yourself running behind the bus.
Drs. Beran and West, the two instruc-
tors who accompanied the students at the
students' invitation, really appreciated
this opportunity to break down some of
the barriers that develop between the stu-
dents and the instructors. Both of them
felt that this was a very worthwhile and
rewarding experie11ce.
Those students who went, hope that
next year's junior class can have 100%
attendance, for this was an experience
that most of them will not forget for
many years to come.
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